Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in european kidney cancers
β Scribed by Maryse Bailly; Christine Bain; Marie-C. Favrot; Mehmet Ozturk
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 917 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Somatic mutations of von Hippel Lindau (VHL) tumorsuppressor gene have been identified in kidney cancers from North America and Japan. We studied VHL gene mutation in 3 I kidney tumors from France. Of these tumors, 45% (14/31) displayed mutations, 60% of which occurred at AT base pairs. The frequency and the spectrum of mutations identified in kidney tumors from EuroDe were similar to those renorted for tumok from other geographical locations.
π SIMILAR VOLUMES
Communicated by Victor A. McKusick von Hippel-Lindau disease (VHL) is an inherited neoplastic disorder characterized by the development of tumors in the eyes, brain, spinal cord, inner ear, adrenal gland, pancreas, kidney, and epididymis. The VHL tumor suppressor gene was identified in 1993. Initial
## Communicated by Lap-Chee Tsui Von Hippel-Lindau (VHL) disease is a dominantly inherited disorder predisposing those afflicted to hemangioblastomas of the central nervous system and the retina, renal cell carcinomas, pheochromocytomas, and pancreatic tumors. The disease has been associated with
## Abstract We previously identified 9 genes (i.e., thymosin Ξ²4, secreted protein acidic and rich in cysteine, Cap43, ceruloplasmin, serum amyloid A, heat shock protein 90, LOT1, osteopontin and casein kinase IΞ³) that are more highly expressed in cancerous regions than in noncancerous regions in hu